APO Research
Talk to an analyst

APO RESEARCH · REPORT

Exosome Medical Technology

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Exosome Medical Technology Market Outlook and Growth Opportunities 2026

4 January 2026191 pages

Choose your research edition.

Industry ResearchExosome Medical Technology Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Exosome Medical Technology Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Exosome Medical Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exosome Medical Technology Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Exosome Medical Technology Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Exosome Medical Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Exosome Medical Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Exosome Medical Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exosome Medical Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Exosome Medical Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Exosome Medical Technology market include Aegle Therapeutics, Anjarium Biosciences, Aruna Biomedical, Carmine Therapeutics, Evox Therapeutics, Exosome Diagnostics, Inc., ExonanoRNA LLC.,, Codiak BioSciences and Esperite Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Exosome Medical Technology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Exosome Medical Technology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Exosome Medical Technology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Exosome Medical Technology market.

Exosome Medical Technology Segment by Company

Aegle Therapeutics

Anjarium Biosciences

Aruna Biomedical

Carmine Therapeutics

Evox Therapeutics

Exosome Diagnostics, Inc.

ExonanoRNA LLC.,

Codiak BioSciences

Esperite Group

Tavec Pharmaceuticals

Exosome Medical Technology Segment by Type

Transmission Electron Microscopy

Nanoparticle Tracking Analysis

Western Blot Molecular Marker Detection

Exosome Medical Technology Segment by Application

Healthcare Providers

Pharmaceutical & Biotechnology Companies

Others

Exosome Medical Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Exosome Medical Technology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Exosome Medical Technology key companies, revenue, market share, and recent developments.

3. To split the Exosome Medical Technology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Exosome Medical Technology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Exosome Medical Technology significant trends, drivers, influence factors in global and regions.

6. To analyze Exosome Medical Technology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Medical Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exosome Medical Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Medical Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exosome Medical Technology industry.

Chapter 3: Detailed analysis of Exosome Medical Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Exosome Medical Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Exosome Medical Technology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Exosome Medical Technology Industry Trends Table 2. Exosome Medical Technology Industry Drivers Table 3. Exosome Medical Technology Industry Opportunities and Challenges Table 4. Exosome Medical Technology Industry Restraints Table 5. Global Exosome Medical Technology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Exosome Medical Technology Revenue Share by Company (2021-2026) Table 7. Global Exosome Medical Technology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Exosome Medical Technology Key Company Manufacturing Base & Headquarters Table 9. Global Exosome Medical Technology Company, Product Type & Application Table 10. Global Exosome Medical Technology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Exosome Medical Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Transmission Electron Microscopy Table 15. Significant Companies of Nanoparticle Tracking Analysis Table 16. Significant Companies of Western Blot Molecular Marker Detection Table 17. Global Exosome Medical Technology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Exosome Medical Technology Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Exosome Medical Technology Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Exosome Medical Technology Sales Value Share by Type (2021-2026) Table 21. Global Exosome Medical Technology Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Healthcare Providers Table 23. Significant Companies of Pharmaceutical & Biotechnology Companies Table 24. Significant Companies of Others Table 25. Global Exosome Medical Technology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Exosome Medical Technology Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Exosome Medical Technology Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Exosome Medical Technology Sales Value Share by Application (2021-2026) Table 29. Global Exosome Medical Technology Sales Value Share by Application (2027-2032) Table 30. Global Exosome Medical Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Exosome Medical Technology Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Exosome Medical Technology Sales Value Share by Region (2021-2026) Table 33. Global Exosome Medical Technology Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Exosome Medical Technology Sales Value Share by Region (2027-2032) Table 35. Global Exosome Medical Technology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Exosome Medical Technology Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Exosome Medical Technology Sales Value Market Share by Country (2021-2026) Table 38. Global Exosome Medical Technology Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Exosome Medical Technology Sales Value Market Share by Country (2027-2032) Table 40. Aegle Therapeutics Company Information Table 41. Aegle Therapeutics Business Overview Table 42. Aegle Therapeutics Exosome Medical Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Aegle Therapeutics Exosome Medical Technology Product Portfolio Table 44. Aegle Therapeutics Recent Development Table 45. Anjarium Biosciences Company Information Table 46. Anjarium Biosciences Business Overview Table 47. Anjarium Biosciences Exosome Medical Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Anjarium Biosciences Exosome Medical Technology Product Portfolio Table 49. Anjarium Biosciences Recent Development Table 50. Aruna Biomedical Company Information Table 51. Aruna Biomedical Business Overview Table 52. Aruna Biomedical Exosome Medical Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Aruna Biomedical Exosome Medical Technology Product Portfolio Table 54. Aruna Biomedical Recent Development Table 55. Carmine Therapeutics Company Information Table 56. Carmine Therapeutics Business Overview Table 57. Carmine Therapeutics Exosome Medical Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Carmine Therapeutics Exosome Medical Technology Product Portfolio Table 59. Carmine Therapeutics Recent Development Table 60. Evox Therapeutics Company Information Table 61. Evox Therapeutics Business Overview Table 62. Evox Therapeutics Exosome Medical Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Evox Therapeutics Exosome Medical Technology Product Portfolio Table 64. Evox Therapeutics Recent Development Table 65. Exosome Diagnostics, Inc. Company Information Table 66. Exosome Diagnostics, Inc. Business Overview Table 67. Exosome Diagnostics, Inc. Exosome Medical Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Exosome Diagnostics, Inc. Exosome Medical Technology Product Portfolio Table 69. Exosome Diagnostics, Inc. Recent Development Table 70. ExonanoRNA LLC., Company Information Table 71. ExonanoRNA LLC., Business Overview Table 72. ExonanoRNA LLC., Exosome Medical Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. ExonanoRNA LLC., Exosome Medical Technology Product Portfolio Table 74. ExonanoRNA LLC., Recent Development Table 75. Codiak BioSciences Company Information Table 76. Codiak BioSciences Business Overview Table 77. Codiak BioSciences Exosome Medical Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Codiak BioSciences Exosome Medical Technology Product Portfolio Table 79. Codiak BioSciences Recent Development Table 80. Esperite Group Company Information Table 81. Esperite Group Business Overview Table 82. Esperite Group Exosome Medical Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Esperite Group Exosome Medical Technology Product Portfolio Table 84. Esperite Group Recent Development Table 85. Tavec Pharmaceuticals Company Information Table 86. Tavec Pharmaceuticals Business Overview Table 87. Tavec Pharmaceuticals Exosome Medical Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Tavec Pharmaceuticals Exosome Medical Technology Product Portfolio Table 89. Tavec Pharmaceuticals Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Exosome Medical Technology Product Image Figure 2. Global Exosome Medical Technology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exosome Medical Technology Market Size (2021-2032) & (US$ Million) Figure 4. Global Exosome Medical Technology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Transmission Electron Microscopy Image Figure 8. Nanoparticle Tracking Analysis Image Figure 9. Western Blot Molecular Marker Detection Image Figure 10. Global Exosome Medical Technology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Exosome Medical Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Exosome Medical Technology Sales Value Share by Type (2021-2032) Figure 13. Healthcare Providers Image Figure 14. Pharmaceutical & Biotechnology Companies Image Figure 15. Others Image Figure 16. Global Exosome Medical Technology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Exosome Medical Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Exosome Medical Technology Sales Value Share by Application (2021-2032) Figure 19. Global Exosome Medical Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Exosome Medical Technology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Exosome Medical Technology Sales Value (2021-2032) & (US$ Million) Figure 22. North America Exosome Medical Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Exosome Medical Technology Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Exosome Medical Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Exosome Medical Technology Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Exosome Medical Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Exosome Medical Technology Sales Value (2021-2032) & (US$ Million) Figure 28. South America Exosome Medical Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Exosome Medical Technology Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Exosome Medical Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Exosome Medical Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Transmission Electron Microscopy
  • Nanoparticle Tracking Analysis
  • Western Blot Molecular Marker Detection
Applications
  • Healthcare Providers
  • Pharmaceutical & Biotechnology Companies
  • Others
Companies covered
  • Aegle Therapeutics
  • Anjarium Biosciences
  • Aruna Biomedical
  • Carmine Therapeutics
  • Evox Therapeutics
  • Exosome Diagnostics, Inc.
  • ExonanoRNA LLC.,
  • Codiak BioSciences
  • Esperite Group
  • Tavec Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Exosome Medical Technology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Exosome Medical Technology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Exosome Medical Technology Market Dynamics
  1. 2.1 Exosome Medical Technology Industry Trends
  2. 2.2 Exosome Medical Technology Industry Drivers
  3. 2.3 Exosome Medical Technology Industry Opportunities and Challenges
  4. 2.4 Exosome Medical Technology Industry Restraints
3 Exosome Medical Technology Market by Company
  1. 3.1 Global Exosome Medical Technology Company Revenue Ranking in 2025
  2. 3.2 Global Exosome Medical Technology Revenue by Company (2021-2026)
  3. 3.3 Global Exosome Medical Technology Company Ranking (2024-2026)
  4. 3.4 Global Exosome Medical Technology Company Manufacturing Base and Headquarters
  5. 3.5 Global Exosome Medical Technology Company Product Type and Application
  6. 3.6 Global Exosome Medical Technology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Exosome Medical Technology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Exosome Medical Technology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Exosome Medical Technology Market by Type
  1. 4.1 Exosome Medical Technology Type Introduction
  2. 4.1.1 Transmission Electron Microscopy
  3. 4.1.2 Nanoparticle Tracking Analysis
  4. 4.1.3 Western Blot Molecular Marker Detection
  5. 4.2 Global Exosome Medical Technology Sales Value by Type
  6. 4.2.1 Global Exosome Medical Technology Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Exosome Medical Technology Sales Value by Type (2021-2032)
  8. 4.2.3 Global Exosome Medical Technology Sales Value Share by Type (2021-2032)
5 Exosome Medical Technology Market by Application
  1. 5.1 Exosome Medical Technology Application Introduction
  2. 5.1.1 Healthcare Providers
  3. 5.1.2 Pharmaceutical & Biotechnology Companies
  4. 5.1.3 Others
  5. 5.2 Global Exosome Medical Technology Sales Value by Application
  6. 5.2.1 Global Exosome Medical Technology Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Exosome Medical Technology Sales Value by Application (2021-2032)
  8. 5.2.3 Global Exosome Medical Technology Sales Value Share by Application (2021-2032)
6 Exosome Medical Technology Regional Value Analysis
  1. 6.1 Global Exosome Medical Technology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Exosome Medical Technology Sales Value by Region (2021-2032)
  3. 6.2.1 Global Exosome Medical Technology Sales Value by Region: 2021-2026
  4. 6.2.2 Global Exosome Medical Technology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Exosome Medical Technology Sales Value (2021-2032)
  7. 6.3.2 North America Exosome Medical Technology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Exosome Medical Technology Sales Value (2021-2032)
  10. 6.4.2 Europe Exosome Medical Technology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Exosome Medical Technology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Exosome Medical Technology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Exosome Medical Technology Sales Value (2021-2032)
  16. 6.6.2 South America Exosome Medical Technology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Exosome Medical Technology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Exosome Medical Technology Sales Value Share by Country, 2025 VS 2032
7 Exosome Medical Technology Country-level Value Analysis
  1. 7.1 Global Exosome Medical Technology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Exosome Medical Technology Sales Value by Country (2021-2032)
  3. 7.2.1 Global Exosome Medical Technology Sales Value by Country (2021-2026)
  4. 7.2.2 Global Exosome Medical Technology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Exosome Medical Technology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Exosome Medical Technology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Exosome Medical Technology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aegle Therapeutics
  2. 8.1.1 Aegle Therapeutics Company Information
  3. 8.1.2 Aegle Therapeutics Business Overview
  4. 8.1.3 Aegle Therapeutics Exosome Medical Technology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aegle Therapeutics Exosome Medical Technology Product Portfolio
  6. 8.1.5 Aegle Therapeutics Recent Developments
  7. 8.2 Anjarium Biosciences
  8. 8.2.1 Anjarium Biosciences Company Information
  9. 8.2.2 Anjarium Biosciences Business Overview
  10. 8.2.3 Anjarium Biosciences Exosome Medical Technology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Anjarium Biosciences Exosome Medical Technology Product Portfolio
  12. 8.2.5 Anjarium Biosciences Recent Developments
  13. 8.3 Aruna Biomedical
  14. 8.3.1 Aruna Biomedical Company Information
  15. 8.3.2 Aruna Biomedical Business Overview
  16. 8.3.3 Aruna Biomedical Exosome Medical Technology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aruna Biomedical Exosome Medical Technology Product Portfolio
  18. 8.3.5 Aruna Biomedical Recent Developments
  19. 8.4 Carmine Therapeutics
  20. 8.4.1 Carmine Therapeutics Company Information
  21. 8.4.2 Carmine Therapeutics Business Overview
  22. 8.4.3 Carmine Therapeutics Exosome Medical Technology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Carmine Therapeutics Exosome Medical Technology Product Portfolio
  24. 8.4.5 Carmine Therapeutics Recent Developments
  25. 8.5 Evox Therapeutics
  26. 8.5.1 Evox Therapeutics Company Information
  27. 8.5.2 Evox Therapeutics Business Overview
  28. 8.5.3 Evox Therapeutics Exosome Medical Technology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Evox Therapeutics Exosome Medical Technology Product Portfolio
  30. 8.5.5 Evox Therapeutics Recent Developments
  31. 8.6 Exosome Diagnostics, Inc.
  32. 8.6.1 Exosome Diagnostics, Inc. Company Information
  33. 8.6.2 Exosome Diagnostics, Inc. Business Overview
  34. 8.6.3 Exosome Diagnostics, Inc. Exosome Medical Technology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Exosome Diagnostics, Inc. Exosome Medical Technology Product Portfolio
  36. 8.6.5 Exosome Diagnostics, Inc. Recent Developments
  37. 8.7 ExonanoRNA LLC.,
  38. 8.7.1 ExonanoRNA LLC., Company Information
  39. 8.7.2 ExonanoRNA LLC., Business Overview
  40. 8.7.3 ExonanoRNA LLC., Exosome Medical Technology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ExonanoRNA LLC., Exosome Medical Technology Product Portfolio
  42. 8.7.5 ExonanoRNA LLC., Recent Developments
  43. 8.8 Codiak BioSciences
  44. 8.8.1 Codiak BioSciences Company Information
  45. 8.8.2 Codiak BioSciences Business Overview
  46. 8.8.3 Codiak BioSciences Exosome Medical Technology Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Codiak BioSciences Exosome Medical Technology Product Portfolio
  48. 8.8.5 Codiak BioSciences Recent Developments
  49. 8.9 Esperite Group
  50. 8.9.1 Esperite Group Company Information
  51. 8.9.2 Esperite Group Business Overview
  52. 8.9.3 Esperite Group Exosome Medical Technology Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Esperite Group Exosome Medical Technology Product Portfolio
  54. 8.9.5 Esperite Group Recent Developments
  55. 8.10 Tavec Pharmaceuticals
  56. 8.10.1 Tavec Pharmaceuticals Company Information
  57. 8.10.2 Tavec Pharmaceuticals Business Overview
  58. 8.10.3 Tavec Pharmaceuticals Exosome Medical Technology Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Tavec Pharmaceuticals Exosome Medical Technology Product Portfolio
  60. 8.10.5 Tavec Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst